Position in JNJ
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$10,308,896
+$368,255 QoQ
Shares Held
40,591
-0.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.79%
of 13F equity value
Holder Rank
#1,094
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LEAVELL INVESTMENT MANAGEMENT, INC. holds $56,783,148 across 9 Drug Manufacturers - General names. JNJ ranks #3 (18.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
74,935 | $18,856,643 | |
| 2 | LLY |
ELI LILLY & Co
|
9,341 | $11,203,876 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
40,591 | $10,308,896 | |
| 4 | AMGN |
Amgen Inc
|
17,935 | $6,494,622 | |
| 5 | MRK |
Merck & Co., Inc.
|
41,794 | $5,370,529 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
36,579 | $2,107,681 | |
| 7 | AZN |
Astrazeneca PLC
|
6,562 | $1,244,286 | |
| 8 | PFE |
Pfizer Inc
|
35,669 | $858,909 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,308,896 | 40,591 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $9,940,641 | 40,667 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $8,240,749 | 39,820 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $7,483,736 | 40,361 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $6,110,000 | 40,000 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $6,693,965 | 40,364 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $5,539,235 | 38,302 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $6,402,504 | 39,507 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $5,585,942 | 38,218 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $6,261,476 | 39,582 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $6,245,462 | 39,846 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $6,227,508 | 39,984 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $6,758,016 | 40,829 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $6,449,085 | 41,607 | Shares | Sole | 2023-04-13 | |
| 2022-12-31 | $7,530,236 | 42,628 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $7,065,973 | 43,254 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $7,682,277 | 43,278 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $7,418,847 | 41,860 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $7,166,635 | 41,893 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $7,133,778 | 44,172 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $7,284,967 | 44,221 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $7,267,721 | 44,221 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $6,884,745 | 43,746 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $6,465,560 | 43,428 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $6,053,558 | 43,046 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $5,441,239 | 41,495 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||